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The rates of protoporphyrin IX (PpIX) photodegradation and reappearance after light exposure at 420 and 632 nm
were measured in mouse skin at different times after 1 h topical application of 5-aminolevulinic acid methyl ester
(ALA-Me). After ALA-Me application (1 h) and removal, the ﬂuorescence of PpIX increased for about 1 h, and then
reached a maximum and started to decrease. Reappearance of PpIX ﬂuorescence after exposures (degrading 60%–
80% of the PpIX) was faster for exposures 0.5 h after ALA-Me application than for exposures 3 h. The bleaching rate
was largest in the former case. This indicates that PpIX is located deeper in the skin after 3 h than after 0.5 h,
whereas the pool of ALA-Me in the skin is largest at 0.5 h. In all cases, the reappearance was faster at a skin
temperature of 351C than at 231C. Reappearance of PpIX ﬂuorescence was faster after exposure to light at 420 nm
than at 632 nm. The rate of elimination of PpIX from the volume of detection was faster after 420 nm light irradiation
than that after 632 nm. These ﬁndings are discussed in view of penetration depths of light and ALA-Me, and
diffusion of PpIX.
Key words: 5-aminolevulinic acid methyl ester/kinetics/light exposure/photodynamic therapy/protoporphyrin IX
J Invest Dermatol 125:1039 –1044, 2005
5-aminolevulinic acid (ALA), as well as 5-aminolevulinic acid
methyl ester (ALA-Me), is being used in the treatment of
human skin cancers (Gardlo and Ruzicka, 2002; Morton,
2002; Szeimies and Landthaler, 2002; Taylor and Brown,
2002). These drugs can penetrate the skin and produce
protoporphyrin IX (PpIX) with some selectivity in tumors.
Photodynamic therapy (PDT) then works via singlet oxygen
formation when PpIX is exposed to light. Singlet oxygen has
very strong cytotoxic effects, whereby tumors can be de-
stroyed (Fuchs and Thiele, 1998; Sharman et al, 2000).
Fractionation of the fluence, or applications of different
fluence rates, are topics frequently discussed in connection
with PDT (Gibson et al, 1990; Messmann et al, 1995; de
Bruijn et al, 1999; Iinuma et al, 1999; Robinson et al, 2000,
2003). Delivery of a single, high fluence may deplete the
oxygen level in the irradiated volume (Foster et al, 1993;
Babilas et al, 2003). This will reduce the efficiency of the
treatment. The use of low fluence rates (Gibson et al, 1990;
Foster et al, 1993; Veenhuizen and Stewart, 1995; Sitnik
et al, 1998; Robinson et al, 1998; de Bruijn et al, 1999;
Iinuma et al, 1999), or fluence fractionation (Foster et al,
1993; Messmann et al, 1997; Muller et al, 1998; Iinuma et al,
1999; Robinson et al, 2000, 2003), may improve the situ-
ation, although one has to consider that during long expo-
sure times, vascular damage may occur. Such damage will
also reduce the oxygen level in the tumor and thus impair
both the rate of PpIX appearance and the quantum yield of
cell destruction. Since singlet oxygen has a very short ra-
dius of action because of its short lifetime in tissue (Moan,
1990), the localization pattern of PpIX in the tissue is of
crucial importance for the processes mentioned above.
Furthermore, the effects are dependent on the wavelength
of the exposure light, because of the fact that the penetra-
tion depth of light into tissue is strongly wavelength de-
pendent (Moan et al, 1998).
In this work, we applied ALA-Me topically on normal
mouse skin in vivo for 1 h, and then exposed the skin to
different fluences of either blue or red light at different times
after the application. The kinetics of production of PpIX was
then studied, which would be of great importance to know
for fluence fractionation. It was shown that the rate of PpIX
reappearance is strongly dependent on the wavelength of
the light, as well as on the time interval between drug ap-
plication and light exposure.
Results
After 1-h application of the cream with ALA-Me, the fluo-
rescence of PpIX in the skin increased for about 1 h,
remained constant for another hour, and then decreased
(Fig 1). The PpIX fluorescence was similar at 0.5 and at
3 h. Therefore, these two time points were chosen for
further experiments.
The fluence rates of the two light sources were adjusted
so that the exposure times needed to reduce the PpIX
Abbreviations: ALA, 5-aminolevulinic acid; ALA-Me, ALA-methyl
ester; PDT, photodynamic therapy; PpIX, protoporphyrin IX
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fluorescence in the skin by 50% were in the same range
(Fig 2). For the blue light lamp (420 nm), 1.5 and 2.6 min
exposures were needed for 50% reduction 0.5 and 3 h, after
cream removal, respectively (Fig 2A). For the light emitting
diodes (LED) light (632 nm), the corresponding exposure
times were 2.1 and 4.2 min (Fig 2B). In both cases, the
photodegradation rate of PpIX was larger 0.5 h after cream
removal than 3 h after removal (Fig 2). The rate of PpIX
appearance after light exposure was significantly faster 0.5
h after cream removal than 3 h after cream removal. This
was true both for exposure to blue and to red light (Figs 3
and 4). Furthermore, the appearance of PpIX 0.5 h after
cream removal was faster after blue light exposure than
after red light exposure (Figs 3 and 4). PpIX reappearance
was significantly faster at a skin temperature of 351C than at
a temperature of 231C (Fig 5). In all cases, the shape of the
fluorescence excitation spectra was similar before and after
light-induced degradation of PpIX in the skin (data not
shown).
Moreover, the reactions of skin to PDT with blue and red
light were documented by photos (pictures not shown). In
general, for blue light-PDT after 0.5 h, the skin reaction was
negligible for light exposures of 1 and 3 min, whereas the
skin became pale and significant edema developed for an
exposure of 4 min. This reaction was less expressed when
Figure 1
Production of protoporphyrin IX in normal mouse skin at different
times after 1 h topical application of 20% 5-aminolevulinic acid
methyl ester. The cream with ALA-ME was removed from the skin after
the 1-h application. Error bars represent the standard errors for groups
of three mice.
Figure 2
Decay of protoporphyrin IX fluorescence in mouse skin induced by
exposure to blue (A) or red (B) light at 0.5 or 3 h after removal of
cream. Twenty percent of 5-aminolevulinic acid methyl ester cream
was topically applied for 1 h and then removed. Error bars represent
standard errors for groups of three mice.
Figure3
Rebuilding of protoporphyrin IX fluorescence in mouse skin after
exposure to blue light at 0.5 h (A) or at 3 h (B) after removing the
cream (20% 5-aminolevulinic acid methyl ester was topically ap-
plied for 1 h). The mice were irradiated for 1, 3, or 4 min. Error bars
represent standard errors for groups of three mice.
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the skin was exposed at 3 h than at 0.5 h. For red light-PDT,
slight edema could be seen when the skin was exposed for
7 min 0.5 h after removing the cream. No visible skin
reaction was found when the red light was imparted at 3 h
after removal of the cream.
The rate of PpIX elimination from the volume of detection
was faster after blue light irradiation than that after red light
irradiation (Fig 6). It was of interest to verify whether ALA-
Me itself was stable during PDT with PpIX present. Because
of their lipophilicity when added to the cream, both PpIX
and ALA-Me should be present mainly in its oil compart-
ments. ALA-Me was hardly destroyed by 1O2, even after a
15-min exposure to blue or red light (Table I).
Discussion
The kinetics of PpIX formation induced by ALA-Me in mouse
skin observed in this work (Fig 1) are in general agreement
with earlier findings (Moan et al, 2003). The main purpose of
this work was to study PpIX reappearance after light expo-
sures that degrade a substantial fraction of the PpIX present
in the skin. Knowledge of the kinetics of reappearance
would be valuable in the planning of fractionated PDT.
Since it is known that second-order processes may play
a role in porphyrin photodegradation (Moan et al, 1997), we
decided to carry out the light exposures at time points when
the PpIX fluorescence intensity was similar, either in the
accumulation phase (0–1 h, Fig 1) or in the decay phase
(after 2 h, Fig 1). At 0.5 and 3 h the intensities are similar:
about 70% of the maximal value (Fig 1).
The fact that PpIX synthesis occurs after cream removal
shows that a significant amount of ALA-Me is present as a
pool in the skin. This pool is not completely depleted even 3
h after cream removal, since some PpIX formation occurs at
351C (Fig 5B). The ALA-Me in the pool is probably not sen-
sitive to PDT itself. This is indicated by the data shown in
Table I: ALA-Me exposed to PpIX and light in the cream
induced similar amounts of PpIX in mouse skin as ALA-Me
unexposed to light. Because of their lipophilicity, ALA-Me
and PpIX can be supposed to be localized close to each
other in the oil-containing cream. Therefore, the short dif-
fusion length of 1O2 should be of no hindrance for photo-
degradation of ALA-Me if it were significantly sensitive to
light exposures of the same magnitudes as those applied in
this work.
The decay kinetics of the PpIX fluorescence in normal
mouse skin during light exposure to the blue and red light
Figure 4
Rebuilding of protoporphyrin IX fluorescence in mouse skin after
exposure to red light at 0.5 h (A) or at 3 h (B) after removing the
cream (20% 5-aminolevulinic acid methyl ester was topically ap-
plied for 1 h). Mice were irradiated for 2, 5, or 7 min. Error bars rep-
resent standard errors for groups of three mice.
Figure5
Rebuilding of protoporphyrin IX fluorescence in mouse skin after
exposure to red light for 5 min at 0.5 h (A) or for 7 min at 3 h (B) after
cream removal. The mice were irradiated at 351C (  ) or at 231C (.).
Topical application of 20% 5-aminolevulinic acid methyl ester was car-
ried out on the mice for 1 h. Then the cream was removed. Error bars
represent standard errors for groups of three mice.
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are shown in Fig 2. As a first approximation, the decay
curves can be decomposed into two exponential curves
(Fig 2). After 5–6 min (2.5–3 J per cm2) and 5.5–8 min (30–45
J per cm2) light exposure with the blue and red light lamps,
respectively, 75% of PpIX fluorescence was bleached. The
remaining fluorescence was from PpIX and its photoprod-
ucts (Juzenas et al, 2001), and was more photostable. This
may be because of depletion of oxygen. From in vitro stud-
ies, it is known that the rate of bleaching with a constant
fluence rate may depend on the concentration of oxygen.
Robinson et al (1996) observed an increase in photobleach-
ing rate when increasing the oxygen or the PpIX concen-
tration in the solution. Van Der Veen et al (1997) did not find
any correlation between the initial fluorescence intensity
and the photobleaching rate in the mouse skin. This indi-
cates that second-order processes are not dominating.
Faster initial photodegradation of PpIX was observed
with blue light for both application times (0.5 and 3 h) after
cream removal (Fig 7). The ratio of the light exposure times
of the red and the blue light lamps needed to bleach an
equal fraction of the PpIX was highest in the beginning of
the light exposure and decreased with increasing light
exposure time (Fig 7). When about 75% of the PpIX (fluo-
rescence was bleached according to Fig 2), there was no
significant difference between the cream removal times 0.5
and 3 h or between the lamps (Fig 7). The differences were
largest after 3 h of cream application (Fig 2), which may be
related to the depth distribution of PpIX. Exposure to the
high fluence rate from the red light lamp (90 mW per cm2)
may lead to a faster oxygen depletion compared with the
blue light lamp (9 mW per cm2), resulting in slower bleach-
ing. Faster bleaching is observed at low fluence rates (Rob-
inson et al, 1999; Finlay et al, 2001). The photobleaching
rate of PpIX depends on the oxygen concentration (Robin-
son et al, 1996). During light exposure, stasis or occlusion of
the microvasculature may arise, and the supply of oxygen is
gradually impaired. Xu et al (2004) found that some of these
problems could be reduced by using low fluence rates.
Non-uniform oxygen bleaching could be the reason why the
ratio of the light exposure times of the red and the blue light
lamps needed to bleach an equal fraction of the PpIX was
highest in the beginning of the light exposure (Fig 7).
The photodegradation rate of PpIX was significantly larg-
er 0.5 h after cream removal than 3 h after removal (Fig 2).
Since the exposure time is short, negligible synthesis of
PpIX should occur during exposure. We propose that the
difference in degradation rates is related to the distribution
of PpIX in the skin. It is likely that it is localized deeper at 3 h
than at 0.5 h (Fig 2) and, therefore, PpIX may appear more
photostable.
The yield of photodegradation per incident photon is
about a factor 15–20 larger at 420 nm than at 632 nm, which
can be calculated from the data in Fig 2A and B using the
measured fluence rates (90 mW per cm2 at 632 nm and 9
mW per cm2 at 420 nm). The value of the fluorescence ex-
citation spectrum of PpIX is about 20–27 times larger at 420
nm than at 632 nm (Juzenas et al, 2002). Thus, the pho-
todegradation rate in the detection volume is about 1.4–2.3
times greater for exposure to light at 420 nm than for ex-
posure at 632 nm (Fig 7), which is theoretically expected
Figure 6
Rate of elimination of protoporphyrin IX from mouse skin after
exposure for 3 min to blue light or 5 min to red light. Cream with
20% 5-aminolevulinic acid methyl ester was topically applied on the
skin for 1 h. Then the cream was removed, and light exposure was
imparted 3 h after cream removal. These two exposure times gave
approximately the same bleaching effect. Error bars represent standard
errors for groups of four mice.
Table I. Effect of photodynamic therapy with blue light or red
light on ALA-Me
Blue light Red light
ALA-Me only 0.8  0.1 0.8  0.1
ALA-MeþPpIX 1.0  0.1 0.8  0.1
ALA-MeþPpIXþ light 1.0  0.1 0.8  0.1
The cream with 1% ALA-Me was mixed with 0.005% PpIX and ex-
posed for 15 min to blue light or for 15 min to red light before it was
topically applied for 24 h on the skin. Then, the cream was removed.
Fluorescence intensity (relevant unit) of PpIX in the skin was measured at
0, 1, and 2 h after removal of the cream. Mean  SE from the fluores-
cence measurement of the three time points mentioned above. The group
of ALA-MeþPpIXþ light from the groups of ALA-Me only and ALA-
MeþPpIX was not significantly different (p40.05).
ALA-Me, 5-aminolevulinic acid methyl ester; PpIX, protoporphyrin IX.
Figure7
Ratio of the exposure times of the red and blue light to bleach an
equal fraction of protoporphyrin IX (PpIX) in normal skin of mouse.
The calculations were carried out using data from Fig 2.
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from light diffusion calculations (not shown) if it is assumed
that the difference in light scattering in the skin at the two
wavelengths is of minor importance.
Following light exposure up to 4 min at 420 nm 0.5 h after
cream removal, the appearance of PpIX occurred at almost
the same rate as that of the synthesis in unirradiated skin
(Fig 3A). But, it was slower after exposure at 632 nm, no-
tably for the largest exposures (Fig 4A). This is in agreement
with the observation that ALA-Me seems to be stable in the
cream during PDT. We can also conclude that the enzymatic
machinery involved in PpIX synthesis is not significantly
impaired by PDT at 420 nm (Fig 3A). The fact that some
reappearance of PpIX occurs after the largest exposure at
420 nm but not at 632 nm is remarkable and not easy to
explain. The only difference between the two exposures is
that light penetrates significantly deeper in tissue at 632 nm
than at 420 nm. The penetration depth into rat skin is 0.3
mm at 420 nm and 2 mm at 632 nm (Juzenas et al, 2002).
According to the data for 420 nm (Fig 3A), it is unlikely that
the difference in reappearance rate (Figs 3A and 4A) is re-
lated to enzymatic damage or photodegradation of ALA-
Me. The amount of PpIX in the detection volume decreases
after 2 h in unirradiated skin (Fig 1). Thus, PpIX is either
transported away in the blood stream or converted to non-
fluorescing products, most likely to heme. PDT at 632 nm
acts deeply, and may damage the blood flow and reduce
the oxygen concentration in the skin. Vessel damage would
therefore lead to reduced removal of PpIX through the cir-
culation and/or through heme synthesis, which is oxygen
dependent. Thus, it seems that vessel damage plays no
significant role here. The most likely explanation for the dif-
ference in reappearance after PDT at 420 and 632 nm (Figs
3A and 4A) is diffusion of PpIX into the volume of meas-
urement. This diffusion of intact PpIX would play a larger
role after shallow PDT (420 nm) than after deep PDT (632
nm). More deeply localized PpIX would remain after PDT at
420 nm than after PDT at 632 nm. Removal of PpIX through
the circulation would be faster for deeply localized PpIX
than for shallowly localized PpIX. This is in agreement with
the data shown in Fig 6.
In agreement with earlier work, the rate of PpIX reap-
pearance is larger at 351C than at 231C (Fig 5). We have
earlier found that the temperature dependence of PpIX
synthesis is related to the efficiency of the rate-limiting en-
zyme porphobilinogen deaminase (Moan et al, 1999).
The photographical documentation of the skin reactions
after PDT with red and blue light at different time points are
of interest in view of the kinetic data. Generally, the effects
were larger after exposure to blue light than after exposure
to red light, notably for short ALA-Me application times.
Thus, the edema and paleness of skin seem to originate
from primary reactions in the upper skin layers where blue
light is predominantly absorbed and acts.
In summary, we have shown that the photodegradation
rate of PpIX in mouse skin, as measured by its fluorescence,
is larger if the light exposure is carried out 0.5 h after re-
moval of the ALA-Me cream than when it is carried out 3 h
after cream removal. A different pattern of localization of
PpIX in the skin is probably the reason for this. After light
exposures carried out early (0.5 h after cream removal), the
machinery of PpIX synthesis, as well as the concentration of
ALA-Me, seems to be damaged. At this time point, reap-
pearance of PpIX in the volume of detection is faster after
PDT at 420 nm than after PDT at 632 nm. This may be
related to diffusion of PpIX in the skin. Finally, the reap-
pearance of PpIX was found to be faster at a skin temper-
ature of 351C than at 231C. These findings should be taken
into account when fractioned PDT is being planned.
Materials and Methods
Animals Animal studies were approved by the National Animal
Research Authority (Norway), and were performed according to the
European Convention for the Protection of Vertebrates Used for
Scientific Purposes. Female Balb/c athymic nude mice were ob-
tained from The Norwegian Radium Hospital (Oslo, Norway). At the
start of each experiment, they were 7–8 wk old and weighed 18–25
g. Three mice were housed per cage with an autoclaved filter
covers in a room with subdued light at constant temperature
(241C–261C) and humidity (30%–50%). Food and bedding were
sterilized, and the mice were given water ad libitum in sterilized
bottles. For proper application of the cream, anesthesia, Hypnorm
(Janssen Pharmaceutica B.V., Tilburg, the Netherlands) and Do-
rmicum (Hoffmann-La Roche AG, Basel, Switzerland) (1:1 vol/vol,
approximately 4 mL per kg body weight), was intraperitoneally in-
jected into the mice. The mice awakened within 1 h and appeared
normally active during the ALA-Me application.
Chemicals ALA-Me and PpIX were purchased from Sigma (St
Louis, Missouri). Twenty percent (wt/wt) ALA-Me was dissolved in a
cream (Unguentum, Merck, Darmstadt, Germany). Approximately
0.2 g of the freshly prepared cream was applied to a single spot of
1 cm diameter on normal skin of the mice. Then the spot was
covered with an adhesive dressing (OpSite Flexigrid, Smith and
Nephew Medical, Hull, UK). The cream was left on the skin for 1 h
and then removed. At different times after cream removal, the PpIX
was measured with a fiberoptic probe.
Lamps Exposure of the skin to light was performed using two
lamps. An in-house-produced blue light lamp with four fluorescent
tubes (Philips Lighting, TLK 40 W/03, R.V. Roosendaal, the Neth-
erlands) emited light in the wavelength region 400–460 nm with a
peak at 420 nm. The fluence rate at the surface of the mouse skin
was 9  0.5 mW per cm2 as measured with the photodiode (New-
Port, Model 1815-C, Irvine, California). An LED lamp (PhotoCure
ASA, Oslo, Norway) possess the spectral range 580–670 nm and a
peak wavelength at 632 nm. The fluence rate at the surface of the
mouse skin was 90  4 mW per cm2.
Fluorescence measurements The fluorescence intensity of PpIX
in the skin was determined by means of a fiberoptic probe con-
nected to a Perkin Elmer LS50B spectrofluorimeter (Norwalk, Con-
necticut). The excitation wavelength was set at 407 nm; the slit
width corresponded to a resolution of 10 nm. The emission wave-
length was scanned from 550 to 750 nm.
Fluorescence kinetics The fluorescence of PpIX in the mouse
skin before and after light exposure was measured. The animals
were divided into three experimental groups. Group one: produc-
tion of PpIX in the skin was measured as a function of the time after
removal of ALA-Me; group two: photobleaching and appearance of
PpIX in skin irradiated 0.5 h after cream removal; and group three:
photobleaching and appearance of PpIX in skin irradiated 3 h after
cream removal. ALA-Me was topically applied for 1 h and then
removed.
Temperature control The effect of temperature on the ability of
the skin to resynthesize PpIX after light exposure was studied. The
temperature of the mouse skin was measured with a calibrated thin
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thermocouple (Kane-May Ltd. KM457XP, Welwyn Garden City, UK).
Before light exposure, the mice were administered different
amounts of anesthetics i.p.(0.02–0.07 mL per mouse), which re-
sulted in different skin temperatures.
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